

Q32 Bio (QTTB) stock slips after pricing a $200M public offering at $18.25. Get the details on the deal and share reaction.
You can purchase shares of Q32 Bio (NASDAQ:QTTB) through any online brokerage.
Other companies in Q32 Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Q32 Bio has a consensus price target of $32.67.
The stock price for Q32 Bio (NASDAQ: QTTB) is $9 last updated November 5, 2026 at 4:49 PM EST.
There are no upcoming dividends for Q32 Bio.
Q32 Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Q32 Bio.
Q32 Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its...